Pulnovo Medical Secures New Funding to Boost Global Growth

Author: Dylan Bailey Updated: 05-20-2025 04:54 AM

Pulnovo Medical Announces New Investment to Expand Global Reach

Pulnovo Medical, a renowned pioneer in medical devices focused on pulmonary hypertension and heart failure, has secured a new investment from EQT Group, a prominent global private equity firm. This partnership symbolizes an exciting new chapter for the company, which continues to receive unwavering support from Qiming Venture Partners.

Impact of CE-MDR Certification on Global Expansion

This recent investment comes on the heels of Pulnovo Medical receiving CE-MDR certification, a significant achievement that positions the company to broaden its treatment options for pulmonary hypertension on a global scale. The injection of capital from EQT is expected to propel the company’s efforts in international clinical trials, necessary regulatory approvals, and further commercialization of its innovative technology.

Innovations in Cardiovascular Devices

Founded in 2013, Pulnovo Medical has dedicated itself to addressing crucial gaps in cardiovascular care. The firm innovates a first-of-its-kind medical device rooted in pulmonary artery denervation (PADN) technology. In 2021, it earned the prestigious Breakthrough Device designation from the US FDA, followed by a Humanitarian Use Device designation in 2023. Additionally, the company’s catheter and generator obtained the China NMPA Approval as a breakthrough device in late 2023, with FDA clearance for the 9F sheath granted in 2024. Most notably, in March 2025, the company achieved CE-MDR certification, marking a pivotal step toward its global commercialization goals.

Expert Insights on the Partnership

Expressing enthusiasm about the partnership, Zoe Zhu, the Director on EQT's Private Capital Asia advisory team, highlighted the pressing clinical needs faced by patients with pulmonary hypertension and heart failure. Zhu stated, "Pulnovo's PADN solution offers renewed hope for these patients, backed by strong clinical evidence that supports improved outcomes. EQT is eager to contribute to Pulnovo Medical's journey by utilizing our deep healthcare expertise and extensive global network to advance their mission of delivering groundbreaking cardiovascular solutions to those in need worldwide."

Commitment to Addressing Unmet Clinical Needs

Cynthia Chen, Chairwoman and Executive Chair of Pulnovo Medical, expressed her gratitude towards EQT and Qiming Venture Partners for their sustained trust and partnership. She remarked, "From the very beginning, Pulnovo Medical has remained committed to addressing genuine clinical needs and developing original, scalable solutions grounded in frontline care. While navigating the path to transform clinical innovation into global standards can be challenging, we are steadfast in our mission to provide meaningful, science-based medical solutions to patients around the world."

Frequently Asked Questions

What is Pulnovo Medical's primary focus?

Pulnovo Medical specializes in developing medical devices for pulmonary hypertension and heart failure.

What recent achievement has Pulnovo Medical accomplished?

Pulnovo Medical recently received CE-MDR certification, signifying compliance with European medical device regulations.

Who are Pulnovo Medical's significant investors?

Pulnovo Medical's key investors include EQT Group and Qiming Venture Partners.

What is the significance of the new investment?

The investment will support Pulnovo Medical's expansion into international markets and facilitate clinical trials.

What technology does Pulnovo Medical use?

Pulnovo Medical utilizes pulmonary artery denervation (PADN) technology in its medical devices.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.